A number of setbacks, controversies and lawsuits keep the German cannabis market in limbo.
In the second part of this series, Roger Brauninger tells us about state regulations and their approach to laboratory accreditation.
Potency and homogeneity testing for medical concentrates and infused products will be required November 1st.
The state is taking a more public and educational approach to their outreach efforts.
The International Association of Cannabis Medicines brought some of the latest research and technology to Cologne.
A lawsuit where a biotech company tries to defend their proprietary extracting technology could set an important new precedent.
In this series, we sit down with experts from A2LA to learn about cannabis lab accreditation.
ACT Labs and Keystone State Testing are the first two labs to gain approval.
G3 Labs had their license suspended due to an undisclosed compliance issue.
The advisory was issued after authorities detected the presence of Avermectin, an insecticide not approved for use on cannabis.